TRPV1: A target for rational drug design

88Citations
Citations of this article
142Readers
Mendeley users who have this article in their library.

Abstract

Transient Receptor Potential Vanilloid 1 (TRPV1) is a non-selective, Ca2+ permeable cation channel activated by noxious heat, and chemical ligands, such as capsaicin and resiniferatoxin (RTX). Many compounds have been developed that either activate or inhibit TRPV1, but none of them are in routine clinical practice. This review will discuss the rationale for antagonists and agonists of TRPV1 for pain relief and other conditions, and strategies to develop new, better drugs to target this ion channel, using the newly available high-resolution structures.

Cite

CITATION STYLE

APA

Carnevale, V., & Rohacs, T. (2016, September 23). TRPV1: A target for rational drug design. Pharmaceuticals. MDPI AG. https://doi.org/10.3390/ph9030052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free